News Center

Home page

Peak Report

News reports

All subordinate units of the group commend the annual advanced

Release time:

2022-02-08

2021 , and arrange the work for the new year. # July 19

, at the

2021 work summary commendation meeting held by Yunnan Jianfeng Cement Company, Liu Shenghua, general manager of Yunnan Jianfeng, made a work report on behalf of Yunnan Jianfeng management team, summarizing the production and operation of 2021 . 2021 Yunnan Peak overcame the impact of the epidemic and new regional capacity, the general price increase of raw combustion materials, the difficulties of low-cost market competition in the release of capacity by peers in the region, and the difficulties of peak production due to power-limiting policies and high-energy-consuming industries for the purpose of reducing carbon emissions. In the difficult market environment, to ensure the peak in the regional volume, price, the overall lead, in the absence of key project support to maintain the regional cement sales of the highest enterprises, effectively maintain and improve the market share of the peak brand. Liu Shenghua objectively analyzed the problems and deficiencies in the previous work, and put forward suggestions on the business objectives, key work plans, work requirements and safeguard measures for 2022 in combination with the actual work in 2021 . The meeting commended the advanced collectives, advanced teams, advanced departments and advanced individuals who have made remarkable achievements in the work of 2021

. Representatives of advanced departments and advanced individuals made typical speeches. Fang Xuhua, secretary of the Yunnan Jianfeng Party Branch, deputy general manager, and chairman of the labor union, hopes that all cadres and employees will take the advanced as an example and benchmark, find gaps based on their positions, everyone talks about performance than dedication, and is in line with the advanced, in the face of heavy production and operation tasks, Strive to catch up and surpass head-on this year and set new highs.

1 July 20

, daye peak cement company held a summary commendation meeting. Zhang Fengliang, deputy general manager of the group company and general manager of daye peak, made a work report for

2021 . 2021 , facing the adverse effects of "carbon peak, carbon neutral " , energy consumption double control policy, price rise of raw fuel materials, daye peak maintained and carried forward the work style of "fight, rob, real " , overcome the external environment changes such as market ups and downs, coal price rise sharply, and continued to promote technological transformation, continuously solve the bottleneck restricting production, technical and economic indicators continue to improve, production capacity, sales can be effectively played. Zhang Fengliang analyzed the challenges faced by the cement industry in the future and the shortcomings in the internal management of the enterprise. He asked all managers to evaluate their employees well, reward and praise their good behavior through the red list in a timely manner, guide and encourage employees with poor performance, encourage them to learn from the advanced and create a good working atmosphere. All employees should cherish their current jobs and encourage them to continuously improve their abilities, strengthen responsibility, become the backbone of the enterprise and future project development, and grow together with the peak; all employees should further improve their execution, based on their own work, and do a solid job in various tasks. The meeting also issued honorary certificates to representatives of advanced individuals and advanced collectives. Yin Weixiong, representative of the electricians class of the manufacturing department, and Cao Jiangfeng, representative of advanced individuals, spoke on behalf of advanced collectives and advanced individuals respectively. Wang Yuhua, manager of the comprehensive management department, explained to the conference on personnel-related systems. All the delegates at the conference reviewed and voted on salary management, attendance management system, labor contract management system and monthly evaluation management system. At the annual summary commendation meeting of Huang ping peak cement company 2021

held on the afternoon of

July

20 , Hu hongwei, general manager of Huang ping peak cement company, made an annual work report of 2021 to the conference, this paper makes a comprehensive summary and review of the work in 2021 from nine aspects, including the completion of production and operation, quality management, marketing management, procurement management, safety and environmental protection, human resources, external coordination, party and industrial group work, and technological transformation work. It also makes a strategic layout and sets work objectives for the work in 2022 . Lu Hongzheng, deputy general manager of Huang Ping Jianfeng, read out the list of advanced collectives and individuals within the group company and the enterprise in 2021

on behalf of Huang Ping Jianfeng. In a warm atmosphere, the advanced representatives within the enterprise came to the stage wearing red ribbons to receive the award. In his speech, the advanced representative said that he would make persistent efforts in the new year, carry forward the fine tradition of passing on and leading the peak, and lead the peak people to build Huang Ping into a benchmark enterprise in Qiandongnan Prefecture.

1 May 27

, the summary commendation meeting held by Jianfeng Pharmaceutical Company presented awards to advanced collectives and outstanding individuals, summarized the work of the previous year, deployed the work of the new year, and signed the target responsibility system for the next year with the heads of subordinate enterprises. In the work report, Huang Jinlong, deputy general manager of

group company and general manager of pharmaceutical company, summarized the achievements made by pharmaceutical company in adjusting internal management structure, organization setting, sales area optimization, integrating financial accounting system, optimizing process, strengthening quality control, project construction and information construction in the previous year. In the face of frequent national pharmaceutical industry policies, drug collection speed expansion, continuous promotion of the status quo, pharmaceutical companies next year will pay more attention to medical insurance, basic drugs, key monitoring and other catalogs, focus on doing a good job in the market access of drugs around the work, innovative marketing system, tap product advantages, enhance market expansion capacity.

Chairman of the Group Company and Chairman of the Pharmaceutical Company Jiang Xiaomeng and the management team of the Pharmaceutical Company presented awards to advanced collectives and outstanding individuals. Wu Weisheng, He Songqin, Wang Liqin, and Chen Yumiao respectively represented the group's outstanding management workers, Advanced collectives, outstanding scientific and technological workers and outstanding members delivered acceptance speeches.

In the concluding speech of the meeting, Jiang Xiaomeng commented on the work of the pharmaceutical company in the previous year and put forward guidance on the work direction of the peak pharmaceutical sector 2022

. He emphasized that the group company has always placed high hopes on the future development of pharmaceutical companies. Pharmaceutical companies must break through their inherent thinking, seize profit points, and improve weak points. Find the right track, develop ophthalmic drugs, strengthen the development of improved drugs, power medical intermediates. Compact responsibility, seriously reflect on the review, find ways to improve the speed of new drug development, clear idle capacity. The combination of sales guarantee and increase, open the sales market, broaden the sales channels, guarantee the quantity of basic products, seize the market opportunity to create benefits, and strive to greatly increase the sales volume. Improve quality and reduce costs in production, starting from the procurement of raw materials, the quality of production workers and the improvement of production processes to reduce production costs. Work together in many ways to get out of the bottleneck and reach the annual goal for the new year.

1 January 28

, the cable company used the morning meeting platform to summarize and commend. Zhang Ci, general manager of the cable company, made the annual work report of

2021 . She reviewed the work of 2021 and put forward requirements for the work of 2022 around the theme of "accelerating technological transformation, increasing efficiency and reducing costs, breaking through self, expanding the market, enabling each other to create benefits " , call on all employees of the cable company to continue to carry forward the work style of "unity, pragmatism and attentiveness " , cherish the achievements of 2021 , strengthen the goal and direction, make strong logarithmic communication cables, make professional subway communication cables, and strive to become the leading position in the subdivided industry. The meeting also commended the advanced collectives and individuals in the year of 2021 . On the afternoon of

, employees summed up the past and shared the future at the summary and commendation meeting of Jianfeng Health Technology Company. The peak health management team presented awards to advanced collectives, outstanding employees and 11 outstanding salesmen. Yin Zhiwu, general manager of Jianfeng Health, said that 2022 , the Jianfeng Health team will work together to firmly believe and unite sincerely, with the business idea of developing healthy products as the main product, supplemented by plant extracts and Chinese herbal pieces, strive to create fist products, maintain the existing entrusted processing business, enhance the business increment of investment promotion, group purchase, terminal and 11 , and make use of agent sales channels; and explore new retail, conference marketing, live broadcast and other new modes; According to the needs of enterprise development, develop products with market competitiveness, organize production and operation in strict accordance with the requirements of GMP and food regulations, strengthen the level of quality supervision, strictly grasp the work of safety and environmental protection, and strive to exceed the targets issued by the group in 2022 . (Qi Jianmei

Wang Yuhua

Pan Yi Chen Shengmu Huang Yuan Zhou Huijuan)

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页